Cargando…
RUNX3 methylation and anti-tumor immunity
Autores principales: | Menheniott, Trevelyan R., Judd, Louise M., Giraud, Andrew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671921/ https://www.ncbi.nlm.nih.gov/pubmed/26682246 |
Ejemplares similares
-
Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific
STAT3 activation and myeloid-derived suppressor cells
por: Däbritz, Jan, et al.
Publicado: (2016) -
IL-1RT1 signaling antagonizes IL-11 induced STAT3 dependent cardiac and antral stomach tumor development through myeloid cell enrichment
por: Buzzelli, Jon N., et al.
Publicado: (2015) -
Myeloid regulatory cells: cross talk of innate and adaptive immunity to maintain the intestinal immune homeostasis in inflammatory bowel disease
por: Däbritz, Jan, et al.
Publicado: (2015) -
Helicobacter pylori CagA Triggers Expression of the Bactericidal Lectin REG3γ via Gastric STAT3 Activation
por: Lee, Kai Syin, et al.
Publicado: (2012) -
IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection
por: Buzzelli, Jon N., et al.
Publicado: (2015)